Study eases concern at antipsychotics use in pregnancy
The use of antipsychotics during pregnancy isn’t linked to childhood neurodevelopmental disorders or learning difficulties, UNSW Sydney-led study shows – giving assurance to those concerned about continuing their medications during pregnancy.
Antipsychotics – a branch of medication designed to treat schizophrenia and bipolar disorder – are important tools for mental health care management. They work by blocking the effect of dopamine, which can help reduce psychotic symptoms such as hallucinations or delusions.
These versatile medications are also widely used for other mental health conditions and developmental disorders, like anxiety, depression, autism spectrum disorder, and insomnia.
But many women and pregnant people using these medications may feel concerned about the potential risks they pose to their unborn baby.
Read more: Study eases concern at antipsychotics use in pregnancy
Latest News & Events
Opinion: Pilot program, Keep Quitting in Mind, found one in nine people who smoke and have a severe mental illness quit the habit
March 18, 2024A smoking cessation pilot program Keep Quitting in Mind – designed specifically for people living with severe mental illness – has helped one in nine participants quit smoking, demonstrating the positive impacts that are possible for an at-risk yet typically overlooked population group.
Promising results for smoking cessation program as one in nine participants quit the habit
March 18, 2024A smoking cessation program, Keep Quitting in Mind (KQIM), for people living with mental illness has resulted in one in nine participants quitting the habit and many others reducing their daily smoking by half.
Launch of world-first guidelines for the treatment of first responders with PTSD
March 18, 2024Black Dog Institute and UNSW Sydney launched new guidelines for the management of PTSD among emergency service workers on Thursday, 21 March in NSW Parliament with Emergency Management Minister Jihad Dib and Mental Health Minister Rose Jackson.
Mindgardens Neuroscience Network acknowledges the Traditional Owners of Country throughout Australia and recognises their continuing connection to land, waters and community. We pay our respect to them and their cultures, and to Elders past, present and emerging.
We acknowledge the voices of people with lived experience, their carers, families and kinship groups. We recognise the expertise acquired through living with a mental health, drug and alcohol or neurological disorder and acknowledge those who care for people on their recovery journey. We place lived experience at the heart of all that we do.
Launch of world-first guidelines for the treatment of first responders with PTSD
Brings together the strengths of four founding organisations
